| Filed On | Filing |
|---|---|
| 14 Aug 2026 | SCHEDULE 13G/A |
| 05 Aug 2026 | 10-Q |
| 05 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 29 Jul 2026 | SCHEDULE 13G/A |
| 23 Jul 2026 | FORM 4 |
| 15 Jul 2026 | FORM 4 |
| 15 Jul 2026 | FORM 4 |
| 14 Jul 2026 | FORM 3 |
| 10 Jul 2026 | FORM 4 |
| 10 Jul 2026 | FORM 4 |
| 10 Jul 2026 | FORM 4 |
| 10 Jul 2026 | FORM 3 |
| 10 Jul 2026 | FORM 4 |
| 10 Jul 2026 | FORM 4 |
| 10 Jul 2026 | FORM 4 |
| 10 Jul 2026 | FORM 4 |
| 09 Jul 2026 | FORM 4 |
| 09 Jul 2026 | FORM 4 |
| 06 Jul 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 06 Jul 2026 |
8-K/A: Departure/Election of Directors or Officers; Compensation
1 Private & Confidential July 2026 Albert Manzone Dear Albert, Perrigo Pharma International D.A.C (Perrigo) is pleased to offer you the position of Interim President and Chief Executive Officer. Our employment offer is subject to the ter... |
Loading...
